Clinical trial
Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years
NCT00285389 · French Innovative Leukemia Organisation, Other · Completed
Key facts
| NCT number | NCT00285389 |
|---|---|
| Title | Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years |
| Official title | Treatment in First Line of Mantle Cell Lymphoma for Patients Under 66 Years by the VAD-CHLORAMBUCIL -Rituximab Regimen Followed by Intensification and Autologous PBSC Transplantation After Marrow Purging With Rituximab |
| Lead sponsor | French Innovative Leukemia Organisation, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mantle Cell Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Adriblastin, dexamethasone, Chlorambucil, rituximab, cyclophosphamide, alkeran, Total body irradiation (8Gy/4fr), vincristine |
| Enrollment | 39 |
| Start date | Feb 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2008 |
| First posted | Feb 2, 2006 |
| Last update posted | Feb 12, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: